Antibodies, Monoclonal, Humanized
Concept
Vocabulary Service
Overview
subject area of
-
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis Academic Article
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Academic Article
-
A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies Academic Article
-
A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice Academic Article
-
A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies Academic Article
-
A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207 Academic Article
-
A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS) Academic Article
-
A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab Academic Article
-
A halotyrosine antibody that detects increased protein modifications in asthma patients Academic Article
-
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial Academic Article
-
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* Academic Article
-
A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection Academic Article
-
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer Academic Article
-
A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors Academic Article
-
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226 Academic Article
-
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis Academic Article
-
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial Academic Article
-
A real‐world, observational study of erenumab for migraine prevention in Canadian patients Academic Article
-
A review of cost–effectiveness of palivizumab for respiratory syncytial virus Academic Article
-
Abelacimab for Prevention of Venous Thromboembolism Academic Article
-
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Academic Article
-
Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies Academic Article
-
Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis Academic Article
-
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial Academic Article
-
Adjuvant targeted therapy in early breast cancer Academic Article
-
Adjuvant therapy for early breast cancer: where do we stand today? Academic Article
-
Adjuvant therapy of the very young woman Conference Paper
-
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review Academic Article
-
Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study Academic Article
-
Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study Academic Article
-
Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study Academic Article
-
An Open Letter to Health Canada Academic Article
-
An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab. Academic Article
-
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience Academic Article
-
Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis Academic Article
-
Anti-TNFα therapy in immune-mediated subfertility: State of the art Academic Article
-
Anti-cytokine targeted therapies for ANCA-associated vasculitis Academic Article
-
Antiangiogenic Therapies in Non-Small-Cell Lung Cancer Academic Article
-
Antidotes for Novel Oral Anticoagulants Academic Article
-
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Academic Article
-
Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics Academic Article
-
Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma Academic Article
-
Are late preterm infants as susceptible to RSV infection as full term infants? Academic Article
-
Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial Academic Article
-
Asthma Control, Airway Mucus, and 129Xe MRI Ventilation After a Single Benralizumab Dose Academic Article
-
Asthma exacerbations on benralizumab are largely non‐eosinophilic Academic Article
-
Atypical Femoral Fractures: A Teaching Perspective Academic Article
-
BDNF/TrkB Content and Interaction with Gastrin-Releasing Peptide Receptor Blockade in Colorectal Cancer Academic Article
-
Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study Academic Article
-
Bell's palsy in a patient receiving adalimumab for Crohn's disease Academic Article
-
Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma Academic Article
-
Benralizumab for Prednisone-Dependent Eosinophilic Asthma Associated With Novel STAT3 Loss of Function Mutation Academic Article
-
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity Academic Article
-
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial Academic Article
-
Bevacizumab in advanced lung cancer: in search of the right drug for the right patient. Academic Article
-
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis Academic Article
-
Biologic survival. Academic Article
-
Biosimilars for psoriasis: clinical studies to determine similarity Academic Article
-
Bleeding Complications and Management on anticoagulant therapy Academic Article
-
Briakinumab Academic Article
-
Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors Academic Article
-
CARESS: The Canadian Registry of Palivizumab Academic Article
-
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation Academic Article
-
COMMENTARY: Should Anti-TNF-α Therapy be Offered to Patients with Infertility and Recurrent Spontaneous Abortion?* Academic Article
-
Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed Academic Article
-
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease Academic Article
-
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC Academic Article
-
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Academic Article
-
Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration Academic Article
-
Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation Academic Article
-
Cardiac Troponin Cutoffs: The Importance of Assay Sensitivity and the Patient Population Academic Article
-
Cardiac and Inflammation Biomarker Profile after Initiation of Adjuvant Trastuzumab Therapy Academic Article
-
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial Academic Article
-
Cetuximab in Metastatic Squamous Cell Cancer of the Skin: A Swiss Case Series Academic Article
-
Changing costs and the impact on RSV prophylaxis Academic Article
-
Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis Academic Article
-
Clinical implications of reversal agents for direct oral anticoagulants Academic Article
-
Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis Academic Article
-
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer Academic Article
-
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis Academic Article
-
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials Academic Article
-
Comparison of the Cost of Hospitalization for Respiratory Syncytial Virus Disease Versus Palivizumab Prophylaxis in Canadian Inuit Infants Academic Article
-
Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis Academic Article
-
Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold? Academic Article
-
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis Academic Article
-
Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective Academic Article
-
Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective Academic Article
-
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis Academic Article
-
Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada Academic Article
-
Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey. Academic Article
-
Current strategies in the prevention of respiratory syncytial virus disease Academic Article
-
Cytokine-Based Therapy in Psoriasis Academic Article
-
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery Academic Article
-
Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment Academic Article
-
Dabigatran Reversal with Idarucizumab Academic Article
-
Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature Academic Article
-
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab Academic Article
-
Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Academic Article
-
Denosumab treatment for fibrous dysplasia Academic Article
-
Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis Academic Article
-
Denosumab: mechanism of action and clinical outcomes Academic Article
-
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran Academic Article
-
Detection of Pulmonary Emboli With 99mTc-Labeled Anti–D-dimer (DI-80B3)Fab′ Fragments (ThromboView) Academic Article
-
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease Academic Article
-
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus Academic Article
-
Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19 Academic Article
-
Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age? Academic Article
-
Dual-Agent Molecular Targeting of the ErbB2 Receptor: Killing One Bird With Two Stones Academic Article
-
Dupilumab, severe asthma airway responses, and SARS‐CoV‐2 serology Academic Article
-
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Academic Article
-
Early and late changes in markers of aortic stiffness with breast cancer therapy Academic Article
-
Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme Academic Article
-
Eculizumab for treatment of asthma Academic Article
-
Eculizumab in a Patient with Dense-Deposit Disease Academic Article
-
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer Academic Article
-
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis Academic Article
-
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia Academic Article
-
Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer Academic Article
-
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty Academic Article
-
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study Academic Article
-
Effectiveness at 1 Year of Monthly versus Variable-Dosing Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-related Macular Degeneration Academic Article
-
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia Academic Article
-
Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis Academic Article
-
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma Academic Article
-
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials Academic Article
-
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance Academic Article
-
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study Academic Article
-
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses Academic Article
-
Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma Academic Article
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma Academic Article
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma Academic Article
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma Academic Article
-
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial Academic Article
-
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis Academic Article
-
Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma Academic Article
-
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma Academic Article
-
Emicizumab and thrombosis: The story so far Academic Article
-
Emicizumab state‐of‐the‐art update Academic Article
-
Evolocumab in HIV-Infected Patients With Dyslipidemia Academic Article
-
Exacerbations of Severe Asthma While on Anti–IL-5 Biologics Academic Article
-
Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial Academic Article
-
First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study Academic Article
-
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients Academic Article
-
Fractionation of bovine serum albumin and monoclonal antibody alemtuzumab using carrier phase ultrafiltration Academic Article
-
Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis Academic Article
-
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer Academic Article
-
Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies Academic Article
-
Granulocyte–macrophage colony‐stimulating factor (
GM
‐
CSF
) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐
GM
‐
CSF
monoclonal antibody Academic Article
-
HER2 Testing in a Population-Based Study of Patients With Metastatic Breast Cancer Treated With Trastuzumab Academic Article
-
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study Academic Article
-
Hematopoietic Processes in Eosinophilic Asthma Academic Article
-
Herceptest: Her2 expression and gene amplification in non-small cell lung cancer Academic Article
-
High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention Academic Article
-
Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease Academic Article
-
Hospitalization for Respiratory Syncytial Virus Illness in Down Syndrome Following Prophylaxis With Palivizumab Academic Article
-
How can we reverse bleeding in patients on direct oral anticoagulants? Academic Article
-
Idarucizumab Academic Article
-
Idarucizumab for Dabigatran Reversal Academic Article
-
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Academic Article
-
Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds Academic Article
-
Idarucizumab for dabigatran overdose Academic Article
-
Identifying and Ensuring Optimal Care for All Children at Risk of Developing Serious Respiratory Syncytial Virus Disease: A Canadian Nurses’ Perspective Academic Article
-
Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review Academic Article
-
Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis Academic Article
-
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use. Academic Article
-
Immunotherapies in Dermatologic Disorders Academic Article
-
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis Academic Article
-
In COVID-19, tocilizumab reduces all-cause mortality at 28 d Academic Article
-
In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d Academic Article
-
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms Academic Article
-
Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study Academic Article
-
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors Academic Article
-
Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck Academic Article
-
Indirect comparison: relative risk fallacies and odds solution Academic Article
-
Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab Academic Article
-
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context Academic Article
-
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) Academic Article
-
Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks. Academic Article
-
JAVELIN: avelumab another spear to fight urothelial carcinoma Academic Article
-
KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation Academic Article
-
LDP-02 (Millenium). Academic Article
-
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31 Academic Article
-
Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers Academic Article
-
Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors’ reply Academic Article
-
Locally advanced breast cancer in octogenarian women Academic Article
-
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17 Academic Article
-
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study Academic Article
-
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial Academic Article
-
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes Academic Article
-
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials Conference Paper
-
Managing drug shortages during a pandemic: tocilizumab and COVID-19 Academic Article
-
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial Academic Article
-
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia Academic Article
-
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial Academic Article
-
Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease Academic Article
-
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis Academic Article
-
MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies Academic Article
-
Monitoring and reversal of direct oral anticoagulants Academic Article
-
NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer Academic Article
-
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank Academic Article
-
Nail Psoriasis and Biologics Academic Article
-
Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma Academic Article
-
Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy Academic Article
-
Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab Academic Article
-
Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis. Academic Article
-
Novel method for differentiation between Trastuzumab and host adaptive response Academic Article
-
Novel oral anticoagulants and reversal agents: Considerations for clinical development Academic Article
-
Novel targeted therapies for eosinophilic disorders Academic Article
-
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis Academic Article
-
Omalizumab and the immune system: an overview of preclinical and clinical data Academic Article
-
Omalizumab for asthma in adults and children Academic Article
-
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium Academic Article
-
Optimizing the Delivery of Targeted Research: An Opportunity for Comparative Effectiveness Research Academic Article
-
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma Academic Article
-
Overstated Conclusions of a Pooled Analysis of Bevacizumab in Colon Cancer Academic Article
-
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial Academic Article
-
Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes Academic Article
-
Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need? Academic Article
-
Parameter scanning ultrafiltration: Rapid optimisation of protein separation Academic Article
-
Patient outcomes after anti TNF-α drugs for Crohn’s disease Academic Article
-
Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial Conference Paper
-
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Academic Article
-
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Conference Paper
-
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study Academic Article
-
Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Academic Article
-
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study Academic Article
-
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel Academic Article
-
Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation Academic Article
-
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy Academic Article
-
Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors Academic Article
-
Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer Cells Academic Article
-
Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition Academic Article
-
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics Academic Article
-
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial Academic Article
-
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab Academic Article
-
Preparative separation of monoclonal antibody aggregates by cation-exchange laterally-fed membrane chromatography Academic Article
-
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis Academic Article
-
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma Academic Article
-
Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102 Academic Article
-
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck Academic Article
-
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Academic Article
-
Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer Conference Paper
-
Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis Academic Article
-
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy Academic Article
-
Ranibizumab and the eye Academic Article
-
Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection. Academic Article
-
Reslizumab for Poorly Controlled, Eosinophilic Asthma Academic Article
-
Respiratory Syncytial Virus Prophylaxis in Down Syndrome: A Prospective Cohort Study Academic Article
-
Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations Academic Article
-
Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study Academic Article
-
Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries Academic Article
-
Reversal agents for non-vitamin K antagonist oral anticoagulants Academic Article
-
Reversal of Direct Oral Anticoagulants: Current Status and Future Directions Academic Article
-
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum Academic Article
-
Reversal of direct oral anticoagulants: a practical approach Academic Article
-
Review of Systemic Treatment Options for Adult Atopic Dermatitis Academic Article
-
Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks’ gestational age in Canada Academic Article
-
Role of Biologics in Asthma Academic Article
-
Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma Academic Article
-
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma Academic Article
-
Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study Academic Article
-
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial Academic Article
-
Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression Academic Article
-
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery Academic Article
-
Sample sizes for clinical trials using sputum eosinophils as a primary outcome Academic Article
-
Seasonal Respiratory Syncytial Virus Prophylaxis Based on Predetermined Dates Versus Regional Surveillance Data Academic Article
-
Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab Academic Article
-
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE) Academic Article
-
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study Academic Article
-
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Academic Article
-
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study Academic Article
-
Separation of monoclonal antibody alemtuzumab monomer and dimers using ultrafiltration Academic Article
-
Specific antidotes for bleeding associated with direct oral anticoagulants Academic Article
-
Sputum Hyaluronan and Versican in Severe Eosinophilic Asthma Academic Article
-
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial Academic Article
-
Stroke Rates after Introduction of Vascular Endothelial Growth Factor Inhibitors for Macular Degeneration: A Time Series Analysis Academic Article
-
Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous Academic Article
-
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease Academic Article
-
Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease Academic Article
-
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis Academic Article
-
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Academic Article
-
Targeted therapy for metastatic renal cell carcinoma Academic Article
-
Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1 Academic Article
-
Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how? Academic Article
-
The Demise of Anti–IL-5 for Asthma, or Not Academic Article
-
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations Academic Article
-
The Pediatric Investigators Collaborative Network on Infections in Canada Study of Predictors of Hospitalization for Respiratory Syncytial Virus Infection for Infants Born at 33 Through 35 Completed Weeks of Gestation Academic Article
-
The Real-Life Effectiveness of Palivizumab for Reducing Hospital Admissions for Respiratory Syncytial Virus in Infants Residing in Nunavut Academic Article
-
The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium Academic Article
-
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial Academic Article
-
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence Academic Article
-
The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic Academic Article
-
The cost effectiveness of palivizumab: a systematic review of the evidence Academic Article
-
The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis Academic Article
-
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies Academic Article
-
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma Academic Article
-
The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study Academic Article
-
Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature Academic Article
-
Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma Academic Article
-
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19 Academic Article
-
Tocilizumab versus the Covid19 tempest: All’s well that ends well or much ado about nothing? Academic Article
-
Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early Look. Academic Article
-
Trastuzumab Cardiac Side Effects: Only Time Will Tell Academic Article
-
Treatment of severe facial psoriasis with adalimumab. Academic Article
-
Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk Academic Article
-
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial Academic Article
-
Ustekinumab associated thrombotic thrombocytopenic purpura Academic Article
-
Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab Academic Article
-
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH Academic Article